Abstract:ObjectivesTo identify obstetrical subgroups in which (1) the caesarean delivery (CD) rate may be reduced without compromising safety and (2) CD may be associated with better perinatal outcomes.DesignA multicentre cross-sectional study.Setting19 hospitals in the USA that participated in the Consortium on Safe Labor.Participants228 562 pregnant women in 2002–2008.Main outcome measuresMaternal and neonatal safety was measured using the individual Weighted Adverse Outcome Score.MethodsWomen were divided into 10 su… Show more
“…Using our multivariable model, we were essentially able to compare outcomes from all hospitals after implementation of the program to their own pre-implementation outcomes as well as to the outcomes from other hospitals who had not yet implemented the program at the same calendar time. As well, the use of previously developed and used [5, 6, 18–20] indicators for adverse maternal and neonatal outcomes, the mAOI and WAOS, further strengthens our results. Given the multifaceted nature of the MORE OB program, we considered that indicators capturing multiple components of maternal/newborn care would be more appropriate.…”
Section: Discussionsupporting
confidence: 84%
“…The decision to use these two composite indices was made for several reasons. Using previously-developed measures facilitates comparison between our study and previously published research [5, 6, 18–20]. Further, the MORE OB program is comprehensive and multifaceted, and could affect a number of maternal and newborn outcomes.…”
Background
In 2002, the MORE
OB
(Managing Obstetrical Risk Efficiently) obstetrical patient safety program was phased-in across hospitals in Ontario, Canada. The purpose of our study was to evaluate the effect of the MORE
OB
program on rates of adverse maternal and neonatal outcomes.
Methods
A retrospective cohort study, using province-wide administrative hospitalization data. We included maternal and neonatal records between fiscal years 2002–2003 and 2013–2014, for deliveries taking place at the 67 Ontario hospitals where the MORE
OB
program was implemented between 2002 and 2012. After accounting for institutional mergers and excluding very small hospitals, 55 hospitals (1,447,073 deliveries) were included.
Multivariable logistic and linear mixed effects regression analysis were used, accounting for secular trends, within hospital correlation and over time correlation, and adjusting for a maternal comorbidity index, hospital annual birth volume, and level of care.
The main outcome measure was a composite individual-level indicator of incidence of any adverse events, and a hospital-level score, called the Weighted Adverse Outcome Score (WAOS) capturing both maternal and neonatal adverse outcomes.
Results
Across the 12 years of follow up, there were 98,789 adverse maternal and neonatal outcomes, a rate of 6.83 per 100 deliveries (6.66 per 100 occurring before, 6.91 per 100 during, and 6.84 per 100 after program implementation). The multivariable analysis found no statistically significant decrease in adverse events associated with program implementation (OR for adverse events after versus before =1.11 (95% CI: 1.06 to 1.17, change in mean WAOS score after minus before =0.15 (− 0.36 to 0.67)).
Conclusions
We did not find a reduction in the incidence of maternal and neonatal adverse outcomes associated with the MORE
OB
program, and small yet statistically significant increases in some adverse events were observed.
Electronic supplementary material
The online version of this article (10.1186/s12884-019-2296-5) contains supplementary material, which is available to authorized users.
“…Using our multivariable model, we were essentially able to compare outcomes from all hospitals after implementation of the program to their own pre-implementation outcomes as well as to the outcomes from other hospitals who had not yet implemented the program at the same calendar time. As well, the use of previously developed and used [5, 6, 18–20] indicators for adverse maternal and neonatal outcomes, the mAOI and WAOS, further strengthens our results. Given the multifaceted nature of the MORE OB program, we considered that indicators capturing multiple components of maternal/newborn care would be more appropriate.…”
Section: Discussionsupporting
confidence: 84%
“…The decision to use these two composite indices was made for several reasons. Using previously-developed measures facilitates comparison between our study and previously published research [5, 6, 18–20]. Further, the MORE OB program is comprehensive and multifaceted, and could affect a number of maternal and newborn outcomes.…”
Background
In 2002, the MORE
OB
(Managing Obstetrical Risk Efficiently) obstetrical patient safety program was phased-in across hospitals in Ontario, Canada. The purpose of our study was to evaluate the effect of the MORE
OB
program on rates of adverse maternal and neonatal outcomes.
Methods
A retrospective cohort study, using province-wide administrative hospitalization data. We included maternal and neonatal records between fiscal years 2002–2003 and 2013–2014, for deliveries taking place at the 67 Ontario hospitals where the MORE
OB
program was implemented between 2002 and 2012. After accounting for institutional mergers and excluding very small hospitals, 55 hospitals (1,447,073 deliveries) were included.
Multivariable logistic and linear mixed effects regression analysis were used, accounting for secular trends, within hospital correlation and over time correlation, and adjusting for a maternal comorbidity index, hospital annual birth volume, and level of care.
The main outcome measure was a composite individual-level indicator of incidence of any adverse events, and a hospital-level score, called the Weighted Adverse Outcome Score (WAOS) capturing both maternal and neonatal adverse outcomes.
Results
Across the 12 years of follow up, there were 98,789 adverse maternal and neonatal outcomes, a rate of 6.83 per 100 deliveries (6.66 per 100 occurring before, 6.91 per 100 during, and 6.84 per 100 after program implementation). The multivariable analysis found no statistically significant decrease in adverse events associated with program implementation (OR for adverse events after versus before =1.11 (95% CI: 1.06 to 1.17, change in mean WAOS score after minus before =0.15 (− 0.36 to 0.67)).
Conclusions
We did not find a reduction in the incidence of maternal and neonatal adverse outcomes associated with the MORE
OB
program, and small yet statistically significant increases in some adverse events were observed.
Electronic supplementary material
The online version of this article (10.1186/s12884-019-2296-5) contains supplementary material, which is available to authorized users.
“…This situation is suggestive of a vicious cycle in which nulliparous women receive care that does not allow them to go into labor spontaneously and are subjected to interventions that result in high cesarean section rates in group 1, which was 39.0%, contrasting studies from other countries, such as the Netherlands, where group 1 showed a cesarean section rate of 9.6%13, and in the United States, where this rate was 14.8%. 16 In this study, cesarean section rates in nulliparous women with a single pregnancy and fetus in cephalic presentation (groups 1 and 2) was 49.3%, which was higher than the Lucena FS et al 17 found a cesarean section rate of 35.8% in nulliparous women with a single pregnancy and fetus in cephalic presentation assisted in the Brazilian public health services. Noteworthy is that group 2 (nulliparous women who did not go into labor spontaneously) were the second-largest relative contribution in the global cesarean section rate with 21.5% in São Paulo State, reaching 27.3% in public hospitals in the low urbanized region.…”
Objectives: to analyze the relation between cesarean section rates in SUS childbirth care establishments in São Paulo State and urbanization conditions, according to Robson group classification system. Methods: Sistema de Informação sobre Nascidos Vivos (Live Births Information System) and Cadastro Nacional de Estabelecimentos de Saúde (National Registry of Health Establishments) 2016 databases were analyzed. The studied outcome was cesarean section rates in the establishments, grouped by administration type (public or nonprofit entities) and urbanization condition. Results: the cesarean section rate in SUS childbirth care establishments was 50.5%, ranging from 41.1% in metropolitan regions up to 75.2% in the low urbanized regions. Cesarean section rates in public administration establishments (38.2%) were significantly lower than the nonprofit administration maternity hospitals (62.3%). Robson groups 5 and 2 contributed mostly to the cesarean section global rate (36.6% and 21.5%, respectively). Conclusions: The less urbanized regions showed significantly higher cesarean section rates than the metropolitan and highly urbanized regions. Cesarean section rates of public administration establishments were significantly lower than the nonprofit administration establishments. However, when separated by urbanization condition its difference was only observed in the metropolitan regions.
“…Ideally, the induced labour progresses to a vaginal birth. However, despite randomised controlled trials indicating that IOL does not increase caesarean section rates3 4 outside of the tight confines of trials, the reality for women in high-income nations is that up to ~40% of women having their labours induced will require a caesarean section, this is particularly true if they are nulliparous 5–9…”
IntroductionInduction of labour (IOL) is a common practice. In Australia, up to 40% of women undergoing labour induction will ultimately have a caesarean section. As a biological role for melatonin in the onset and progress of labour has been demonstrated, we aim to test the hypothesis that addition of melatonin will reduce the need for caesarean section.Methods and analysisThis is a double-blind, randomised, placebo-controlled trial in women undergoing IOL at term. We plan to randomise 722 women (1:1 ratio) to receive either melatonin (four doses of 10 mg melatonin: first dose—in the evening at the time of cervical balloon or Dinoprostone PGE2vaginal pessary insertion, second dose—at time of oxytocin infusion commencement, third dose—6 hours after the second dose, fourth dose—6 hours after the third dose) or placebo (same dosing regime). Participants who are having artificial rupture of the membranes only as the primary means of labour induction will receive up to three doses of the trial intervention. The primary outcome measure will be the requirement for a caesarean section. Secondary outcomes will include duration of each stage of labour and time from induction to birth, total dose of oxytocin administration, epidural rate, indication for caesarean section, rate of instrumental deliveries, birth within 24 hours of induction commencement, estimated blood loss, Apgar score at 5 min, neonatal intensive care unit admissions and participant satisfaction. Maternal melatonin levels will be measured immediately before commencement of the oxytocin intravenous infusion and 3 hours after and at the time of birth in order to determine any differences between the two trial arms.Ethics and disseminationThe study is conducted in accordance with the conditions of Monash Health HREC (RES-17-0000-168A). Findings from the trial will be disseminated through peer-reviewed publications and conference presentations.Protocol versionV.7.0, 30 July 2019.Trial registration numberACTRN12616000311459, Universal trial number: (UTN) U1111-1195-3515.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.